Contents
Academy · Research Data, Analytics & AI · PRISMA 2020
The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement replaced a reporting guideline that had not been updated since 2009 with a 27-item checklist designed for a methodological landscape that now includes network meta-analysis, living reviews, automation tools and a considerably more developed understanding of risk of bias.
PRISMA 2020 is the current reporting guideline for systematic reviews, published simultaneously in 2021 across several journals including the BMJ, to replace the 2009 PRISMA statement that had governed systematic review reporting for over a decade1. It was published jointly with its own explanation and elaboration paper, which addresses every checklist item with worked examples drawn from published reviews, so that authors have explicit guidance on what compliance with each item entails in practice2. A reporting guideline does not prescribe how a review should be conducted; it specifies what a completed review must disclose so that readers can appraise its methods and reproduce its search. PRISMA 2020 updated that list of disclosures to reflect methodological developments that the 2009 version had not anticipated, including network meta-analysis, risk-of-bias assessment frameworks, and a substantially larger body of evidence on how incomplete reporting in systematic reviews misleads readers.
Learning objectives
- What changed structurally between PRISMA 2009 and PRISMA 2020
- Which new checklist items PRISMA 2020 added and why
- How PRISMA 2020 relates to its extensions for network meta-analysis, scoping reviews, and individual patient data
Common misconceptions
- “PRISMA is a single fixed checklist that applies the same way to every kind of review.” PRISMA 2020 itself is a base reporting guideline with purpose-built extensions, including PRISMA-NMA for network meta-analysis, PRISMA-ScR for scoping reviews, and PRISMA-IPD for individual-patient-data reviews, each adding items the base checklist does not cover.
Reasons for replacing the 2009 statement
The original PRISMA statement, published in 2009 by Moher and colleagues, itself replaced an earlier guideline called QUOROM and had become the dominant reporting standard for systematic reviews across biomedicine4. By the time PRISMA 2020 was developed, the evidence synthesis field had changed in ways that the 2009 checklist did not address: network meta-analysis had become sufficiently common to require its own extension, formal risk-of-bias tools such as ROB 2 and ROBINS-I had become standard practice, and a large body of methodological research, including Ioannidis's widely cited 2016 analysis of redundant and misleading systematic reviews, had documented how often published reviews omitted information that readers needed to assess their reliability7. PRISMA 2020 was developed through a structured process involving a survey of methodologists, a Delphi consensus exercise, and an in-person meeting, resulting in a reorganized 27-item checklist, a separate 12-item checklist for abstracts, and a revised flow diagram12. The original 2009 statement had nonetheless been of considerable value: it was associated with measurable improvements in the completeness of systematic review reporting in the years after its adoption, which partly explains why the authors of PRISMA 2020 chose to update the underlying approach in response to the field's accumulated methodological advances rather than to redevelop the reporting guideline from first principles4.
Additions introduced in PRISMA 2020
The principal structural change is that PRISMA 2020 explicitly requires reporting of the methods used to assess certainty, or confidence, in the body of evidence for each outcome, reflecting the wider adoption of certainty ratings based on GRADE (Grading of Recommendations Assessment, Development and Evaluation) since 200919. Under the 2009 statement, a review could report a pooled effect estimate and leave readers to infer the confidence warranted from the confidence interval alone; PRISMA 2020 expects the certainty-rating method itself, not only its output, to be named and described in the methods section. It also expanded reporting requirements for risk-of-bias assessment to reflect tools such as ROB 2 for randomized trials and ROBINS-I for non-randomized studies, both of which post-date the original 2009 statement8. This update is significant because a review that still cites the older Cochrane risk-of-bias tool, or that names no tool at all, indicates to an informed reviewer that the methods section has not kept pace with the field's standard practice, irrespective of whether the review's conclusions are sound. The 2020 version added explicit items on the methods used to assess the risk of bias due to missing results, that is, the handling of unpublished or selectively reported outcomes, and introduced a specific 12-item abstract checklist so that the abstract itself, beyond which many readers do not proceed, could be audited for completeness1. The flow diagram was revised to accommodate reviews that search multiple types of sources, including registers and websites, rather than assuming every review searches only bibliographic databases2. PRISMA 2020 also reorganized the section ordering of the checklist to correspond more closely to the logical sequence a reader follows, grouping items under methods, results, and discussion more consistently than the 2009 version had, and it added explicit items addressing automation tools and any use of text-mining or machine-learning assistance during screening, a methodological development that had scarcely existed when the original 2009 checklist was drafted1.
Relationship between PRISMA 2020 and its extensions
PRISMA 2020 is the base statement, and authors conducting a review with a specific design feature are expected to apply the relevant extension in addition to it rather than treat the base checklist as sufficient on its own. PRISMA-NMA, published in 2015, adds items specific to reporting a network of comparisons, including how the network geometry is presented and how inconsistency between direct and indirect evidence is assessed5. PRISMA-ScR, published in 2018, adjusts the checklist for scoping reviews, which map a body of literature rather than pool effect estimates10. PRISMA-IPD, from 2015, covers reviews that reanalyze individual participant data rather than aggregate published results6. Each extension was developed through the same kind of structured consensus process used for the base statement, so the items it adds are not arbitrary but reflect a deliberate judgment by methodologists working in that review design about which reporting gaps were sufficiently common and consequential to warrant a dedicated checklist item. A review that is, for example, both a network meta-analysis and an individual-patient-data synthesis should report against PRISMA 2020 and both relevant extensions, rather than selecting one.
Identifying which extensions apply is of practical importance because journals increasingly request extension-specific compliance at submission, and a reviewer familiar with network meta-analysis methodology, for instance, is likely to notice if a submitted review reports a network of comparisons without addressing how its geometry or inconsistency was assessed, since that is precisely the gap PRISMA-NMA was designed to address5. Earlier extensions published before the 2009-to-2020 transition, including the diagnostic test accuracy extension and the harms extension, were also updated or are being updated to align with PRISMA 2020's structure, which means authors should confirm they are working from the current version of any extension rather than an older one written against the 2009 base statement1.
Substantive use of the checklist
PRISMA 2020's own explanation and elaboration paper is explicit that the checklist is a reporting standard, not a quality-assessment tool: a review can satisfy every checklist item while still containing a methodologically weak synthesis, and a review can be methodologically sound while still reporting poorly3. The practical value of working through the checklist item by item during drafting, rather than applying it retrospectively to a finished manuscript, is that several items, such as specifying the certainty-assessment method or describing how missing-results bias was evaluated, require decisions that are considerably easier to make before data extraction than to reconstruct afterwards3. The Cochrane Handbook's chapter on synthesizing and presenting findings works from the same underlying logic and is a useful companion reference for authors deciding how to structure the synthesis PRISMA 2020 then requires them to report11. In practice, the checklist is used most efficiently as a working document maintained alongside the protocol from the outset: each item becomes a question that the review team answers once, during planning, rather than a retrospective audit item to be reconstructed from memory or from data-extraction files months after the search was run, by which time details such as the exact certainty-assessment method are most easily lost.
Journals vary in how strictly they enforce PRISMA 2020 at submission: some require a completed checklist with page numbers mapped to each item, whereas others treat it as recommended good practice without a mandatory accompanying document. Consulting the author instructions of the target journal before finalizing the structure of the manuscript therefore avoids late structural revision. A submitted PRISMA 2020 checklist that cites page numbers not matching the manuscript content, a common and readily avoidable error, may lead an editor to question the care taken with the rest of the submission, a reputational cost that extends beyond the error itself.
Key points
Key points
PRISMA 2020 is a reorganized, expanded reporting standard, not a quality check, and its principal value lies in working through the 27-item checklist and relevant extensions during planning rather than retrofitting them onto a finished manuscript.
Practical application
Practical application
- Every applicable PRISMA extension should be identified before drafting begins. Authors should determine whether the review requires PRISMA-NMA, PRISMA-ScR or PRISMA-IPD in addition to the base 2020 checklist, since each adds items that the base statement does not cover.
- Certainty and risk-of-bias assessment methods should be decided before data extraction. PRISMA 2020 requires these methods to be reported explicitly, and deciding them early avoids retrofitting a method description after the synthesis is complete.
- The 12-item abstract checklist should be applied separately from the main 27-item checklist. Many readers read only the abstract, and PRISMA 2020 treats its completeness as a distinct reporting requirement.
Frequently asked questions
Many journals require or strongly recommend PRISMA 2020 compliance for systematic reviews, but the requirement is set by individual journals and editorial policies, not by PRISMA itself, so authors should check their target journal's instructions.
The main checklist has 27 items, alongside a separate 12-item checklist specifically for reporting in the abstract.
No. PRISMA 2020 governs what to report; the Cochrane Handbook governs how to conduct and synthesize a review methodologically. The two are complementary rather than competing.
It will likely under-report network-specific elements like geometry and inconsistency assessment, since those items exist only in the PRISMA-NMA extension, not the base checklist.
PRISMA 2020 does not mandate a specific risk-of-bias tool, but it expanded the reporting requirements around whichever tool is used, reflecting the wider adoption of structured tools like ROB 2 and ROBINS-I since 2009.
References
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. read 10 October 2026. View on The BMJ
- Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. read 10 October 2026. View on The BMJ
- Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. read 10 October 2026. View on PubMed Central
- Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009;6(7):e1000097. read 10 October 2026. View on PLOS Medicine
- Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions. Annals of Internal Medicine. 2015;162(11):777-784. read 10 October 2026. View on Annals of Internal Medicine
- Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657-1665. read 10 October 2026. View on JAMA
- Ioannidis JPA. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Quarterly. 2016;94(3):485-514. read 10 October 2026. View on The Milbank Quarterly
- Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. read 10 October 2026. View on The BMJ
- Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. read 10 October 2026. View on The BMJ
- Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine. 2018;169(7):467-473. read 10 October 2026. View on Annals of Internal Medicine
- Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 6.4. Cochrane; 2023. read 10 October 2026. View on Cochrane Training
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews. Pubrica. https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/
Pubrica Academy. “The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews.” Pubrica, 10 Oct. 2026, pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/.
Pubrica Academy (2026) The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews. Pubrica. Available at: https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/ (Accessed: 15 October 2026).
Pubrica Academy. “The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews.” Pubrica. October 10, 2026. https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/
Pubrica Academy, ‘The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/> accessed 15 October 2026.
Pubrica Academy. The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/
Pubrica Academy, “The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/
@misc{/la_prisma_2020_reporting_guideline_2026,
author = {{Pubrica Academy}},
title = {The PRISMA 2020 Statement: An Improved Reporting Guideline for Systematic Reviews},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/systematic-review/the-prisma-2020-statement-an-improved-reporting-guideline-for-systematic-reviews/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
PRISMA 2020 Pre-Writing Checklist
This checklist should be completed before the systematic review manuscript is drafted, not afterwards.
[ ] Confirmed whether any PRISMA extension (NMA, ScR, IPD) applies in addition to base PRISMA 2020 [ ] Decided the risk-of-bias tool and certainty-assessment method before data extraction [ ] Decided how missing-results bias will be assessed and reported [ ] Drafted the flow diagram to reflect every source type actually searched, not just databases [ ] Checked the abstract separately against the 12-item PRISMA 2020 abstract checklist
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica's systematic review support team maps a manuscript against the full PRISMA 2020 checklist and any applicable extension before submission, flagging items that are easier to fix at the planning stage than after the synthesis is complete.